Akari Therapeutics, Plc reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 10.01 million compared to USD 17.75 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.28 USD | +8.01% | +8.47% | -58.98% |
1st Jan change | Capi. | |
---|---|---|
-58.98% | 9.39M | |
-2.62% | 103B | |
+1.79% | 95.28B | |
+1.46% | 22.15B | |
-15.62% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.73% | 16.05B | |
+5.39% | 13.68B | |
+34.40% | 12.17B |
- Stock Market
- Equities
- AKTX Stock
- News Akari Therapeutics, Plc
- Akari Therapeutics, Plc Reports Earnings Results for the Full Year Ended December 31, 2023